Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary...
Secondary HyperparathyroidismDialysisProspective, non-randomized, multi-center study to assess the efficacy and safety of paricalcitol injection or oral administered over 6 months to patients with secondary hyperparathyroidism on dialysis.
Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving...
Kidney DiseaseChronic Kidney DiseaseThe purpose of this study is to evaluate the efficacy and safety of cinacalcet compared with placebo in patients with stage 3 and 4 Chronic Kidney Disease (CKD).
Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium...
Secondary HyperparathyroidismChronic Kidney DiseaseA study to investigate the effects of Zemplar and Calcijex on intestinal calcium absorption in hemodialysis subjects.
SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism...
Secondary HyperparathyroidismEnd Stage Renal DiseaseThe purpose of this study is to demonstrate that the efficacy of cinacalcet when co-administered with the first meal after dialysis is comparable (non-inferior) to the efficacy of cinacalcet when administered during the dialysis study visit.
A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic...
Chronic Kidney DiseaseStage 51 moreThe purpose of this study is to evaluate the effects of Zemplar® Injection and Hectorol® Injection on intestinal calcium absorption in Chronic Kidney Disease Stage 5 subjects on hemodialysis.
Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis
Secondary HyperparathyroidismThis study is designed to evaluate safety, pharmacokinetics and pharmacodynamics after single administration of KHK7580 for secondary hyperparathyroidism in patients receiving peritoneal dialysis.
Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism...
HyperparathyroidismSecondaryThis study is designed to assess the efficacy and safety of etelcalcetide (AMG 416) compared with placebo in the treatment of SHPT in CKD patients receiving hemodialysis.
A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism...
Chronic Kidney DiseaseSecondary HyperparathyroidismThis is a study to evaluate the safety and pharmacokinetics in pediatric patients with secondary hyperparathyroidism receiving a single dose of etelcalcetide at the end of hemodialysis.
Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa)....
Secondary HyperparathyroidismChronic Kidney Disease-Mineral and Bone Disorder3 moreThis is a pilot randomized controlled trial aimed to evaluate the effect of teriparatide on the clinical course of hypocalcemia after parathyroidectomy for secondary hyperparathyroidism in dialysis-dependent patients.
Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary...
HyperparathyroidismSecondaryThe purpose of this study is to characterize the safety and tolerability of single rising doses of etelcalcetide in hemodialysis patients with secondary hyperparathyroidism.